Statin drugs to reduce breast cancer recurrence and mortality

Abstract Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for the treatment of high cholesterol and atherosclerotic coronary artery disease and are widely used. This has engender...

Full description

Bibliographic Details
Main Authors: Colin H. Beckwitt, Adam Brufsky, Zoltán N. Oltvai, Alan Wells
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Breast Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13058-018-1066-z